Free Trial
→ My public warning after 55 years of watching the markets (From Weiss Ratings) (Ad)tc pixel Free ELTP Stock Alerts

Elite Pharmaceuticals (ELTP) Short Interest Ratio & Short Volume

Elite Pharmaceuticals logo
$0.24 0.00 (0.00%)
As of 11/11/2026 03:49 PM Eastern
Compare

Elite Pharmaceuticals Short Interest Overview

As of October 30, 2026, Elite Pharmaceuticals (ELTP) had a short interest of 2.99 million shares sold short, representing 0.32% of the public float. This marks a 1.41% decrease in short interest since the prior report. The short interest ratio (days to cover) is 2.8, meaning it would take 2.8 days of the average trading volume of 550,102 shares to cover all short positions.

Current Short Interest
2,991,818 shares
Previous Short Interest
3,034,556 shares
Change Vs. Previous Report
-1.41%
Dollar Volume Sold Short
$687.82 thousand
Short Interest Ratio
2.8 Days to Cover
Last Record Date
October 30, 2026
Outstanding Shares
1,077,470,000 shares
Short Percent of Float
0.32%
Today's Trading Volume
866,126 shares
Average Trading Volume
550,102 shares
Today's Volume Vs. Average
157%
Short Selling Elite Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Elite Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ELTP Short Interest Over Time

ELTP Days to Cover Over Time

ELTP Percentage of Float Shorted Over Time

Elite Pharmaceuticals Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/30/20262,991,818 shares $687.82 thousand -1.4%0.3%2.76 $0.23
10/15/20263,034,556 shares $770.78 thousand +15.3%0.3%1.75 $0.25
9/30/20262,632,127 shares $636.45 thousand +1.0%0.3%2.24 $0.24
9/15/20262,606,630 shares $651.40 thousand +2.3%0.3%1.55 $0.25
8/31/20262,547,855 shares $732.51 thousand +1.5%0.3%1.35 $0.29
8/14/20262,510,800 shares $778.35 thousand -6.5%0.3%1.25 $0.31
7/31/20262,685,456 shares $1.02 million +3.3%0.3%3.73 $0.38
7/15/20262,599,593 shares $961.59 thousand -2.1%0.3%1.89 $0.37
6/30/20262,654,887 shares $969.30 thousand +2.3%0.3%2.05 $0.37
6/15/20262,594,622 shares $953.52 thousand -0.2%0.3%1.53 $0.37
5/29/20262,599,516 shares $894.23 thousand -0.9%0.3%3.24 $0.34
5/15/20262,622,325 shares $908.11 thousand +6.0%0.3%2.61 $0.35
4/30/20262,473,767 shares $844.79 thousand +1.6%0.3%2.13 $0.34
4/15/20262,435,723 shares $916.81 thousand -0.6%0.3%3.62 $0.38
3/31/20262,449,194 shares $881.95 thousand +6.6%0.3%2.02 $0.36
3/13/20262,298,661 shares $889.81 thousand -6.2%0.2%1.53 $0.39
2/27/20262,449,531 shares $1.00 million -3.5%0.3%1.09 $0.41
2/13/20262,538,952 shares $1.12 million +21.0%0.3%1.67 $0.44
1/30/20262,098,448 shares $920.17 thousand -2.7%0.2%1.47 $0.44
1/15/20262,155,786 shares $1.02 million -2.0%0.2%2.32 $0.48
12/31/20252,198,798 shares $1.08 million -0.4%0.2%1.67 $0.49
12/15/20252,207,729 shares $1.10 million -1.0%0.2%2.02 $0.50
11/28/20252,229,689 shares $1.19 million -5.7%0.2%1.01 $0.53
11/14/20252,365,428 shares $1.60 million +11.1%0.3%1.76 $0.68
10/31/20252,128,899 shares $1.31 million +1.1%0.2%1.69 $0.62
10/15/20252,106,800 shares $1.28 million -7.0%0.2%1.4 $0.61
9/30/20252,265,900 shares $1.45 million +2.5%N/A1.1 $0.64
9/15/20252,210,600 shares $1.51 million -12.3%N/A0.8 $0.69
8/31/20252,521,900 shares $1.73 million +7.0%0.3%0.5 $0.69
8/15/20252,356,000 shares $1.28 million -4.8%N/A0.8 $0.54
7/31/20252,475,200 shares $1.26 million +1.0%0.3%1.6 $0.51
7/15/20252,449,800 shares $1.30 million -4.9%N/A0.5 $0.53
6/30/20252,576,700 shares $1.89 million +11.2%0.3%0.4 $0.73
6/15/20252,317,200 shares $1.56 million +1.0%0.3%0.6 $0.67
5/31/20252,293,300 shares $1.24 million +17.0%0.3%1.4 $0.54
5/15/20251,960,500 shares $885.36 thousand -1.4%0.2%1.4 $0.45
4/30/20251,987,600 shares $822.07 thousand -0.1%N/A2.2 $0.41
4/15/20251,988,500 shares $845.91 thousand +1.0%0.2%0.7 $0.43
3/31/20251,968,400 shares $856.25 thousand -0.8%0.2%1.6 $0.44
3/15/20251,984,000 shares $960.06 thousand +0.1%0.2%1.7 $0.48
My public warning after 55 years of watching the markets (Ad)

Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel

See Martin Weiss's full warning before this risk spreads further
2/28/20251,982,000 shares $970.98 thousand -5.8%0.2%1 $0.49
2/15/20252,105,000 shares $1.12 million +3.6%0.2%0.8 $0.53
1/31/20252,031,600 shares $1.02 million +3.0%N/A1.3 $0.50
1/15/20251,972,500 shares $946.80 thousand -1.8%N/A0.6 $0.48
12/31/20242,008,300 shares $1.09 million -26.1%N/A0.8 $0.54
12/15/20242,717,700 shares $1.34 million +7.6%N/A0.9 $0.49
11/30/20242,526,500 shares $1.49 million +52.7%N/A0.5 $0.59
11/15/20241,654,500 shares $929.00 thousand +6.0%N/A0.4 $0.56
10/31/20241,560,500 shares $692.55 thousand -22.1%N/A0.1 $0.44
10/15/20242,004,100 shares $883.01 thousand -1.6%N/A0.6 $0.44
9/30/20242,036,000 shares $789.97 thousand -7.3%N/A0.6 $0.39
9/15/20242,195,500 shares $790.60 thousand +19.7%N/A0.2 $0.36
8/31/20241,834,800 shares $507.60 thousand +10.5%N/A0.3 $0.28
8/15/20241,661,100 shares $317.44 thousand +5.0%N/A1 $0.19
7/31/20241,581,500 shares $294.16 thousand -9.2%N/A1.4 $0.19
7/15/20241,740,800 shares $330.75 thousand +7.1%N/A1 $0.19
6/30/20241,625,700 shares $323.51 thousand +4.8%N/A1 $0.20
6/15/20241,550,800 shares $261.09 thousand -2.4%N/A2.4 $0.17
5/31/20241,588,700 shares $274.85 thousand +3.8%N/A1.3 $0.17
5/15/20241,530,700 shares $214.14 thousand -4.1%N/A1.3 $0.14
4/30/20241,595,900 shares $207.15 thousand -0.3%N/A1.8 $0.13
4/15/20241,601,300 shares $216.18 thousand +2.9%N/A1.4 $0.14
3/31/20241,555,700 shares $240.11 thousand -7.7%N/A1.4 $0.15
3/15/20241,684,700 shares $234.17 thousand +5.1%N/A0.9 $0.14
2/29/20241,602,900 shares $258.07 thousand +0.9%N/A0.4 $0.16
2/15/20241,588,800 shares $293.77 thousand +75.2%N/A0.5 $0.18
1/15/2024103,200 shares $18.01 thousand +24.8%N/A0 $0.17
12/31/202382,700 shares $11.58 thousand No ChangeN/A0 $0.14
11/30/202380,600 shares $11.08 thousand +58.4%N/A0 $0.14
11/15/202350,900 shares $7.38 thousand No ChangeN/A0 $0.15
10/15/2023228,000 shares $21.83 thousand +113.5%N/A0.3 $0.10
9/30/2023106,800 shares $10.02 thousand +862.2%N/A0.1 $0.09
9/15/202311,100 shares $865.80 -94.8%N/A0 $0.08
8/31/2023211,700 shares $18.63 thousand +1,283.7%N/A0 $0.09
8/15/202315,300 shares $711.45 -74.6%N/A0 $0.05
7/31/202360,300 shares $2.53 thousand +102.4%N/A0 $0.04
7/15/202329,800 shares $1.13 thousand No ChangeN/A0 $0.04
6/15/202311,000 shares $374.00 -7.6%N/A0 $0.03
5/31/202311,900 shares $367.71 +643.8%N/A0 $0.03
5/15/20231,600 shares $49.44 -85.7%N/A0 $0.03
4/30/202311,200 shares $369.60 +3,633.3%N/A0 $0.03
4/15/2023300 shares $9.30 -93.6%N/A0 $0.03
3/31/20234,700 shares $136.30 +193.8%N/A0 $0.03
3/15/20231,600 shares $50.40 -20.0%N/A0 $0.03
2/28/20232,000 shares $71.20 -95.5%N/A0 $0.04
2/15/202344,200 shares $1.70 thousand +44.9%N/A0.1 $0.04
1/31/202330,500 shares $1.03 thousand +74.3%N/A0 $0.03
1/15/202317,500 shares $525.00 +2,087.5%N/A0 $0.03
12/30/2022800 shares $23.60 +700.0%N/A0 $0.03
12/15/2022100 shares $3.00 -99.0%N/A0 $0.03
Drop these 5 stocks before the market opens tomorrow! (Ad)

The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.tc pixel

See the five stocks Weiss Ratings analysts are watching closely now.
11/30/202210,000 shares $329.00 -54.3%N/A0 $0.03
11/15/202221,900 shares $755.55 +1,268.8%N/A0.1 $0.03
10/31/20221,600 shares $57.28 -96.3%N/A0 $0.04
10/15/202242,800 shares $1.33 thousand No ChangeN/A0 $0.03
9/15/2022400 shares $14.40 -99.4%N/A0 $0.04
8/31/202269,300 shares $2.48 thousand -2.8%N/A0 $0.04
8/15/202271,300 shares $3.21 thousand No ChangeN/A0.1 $0.05
7/15/20221,000 shares $42.90 -83.1%N/A0 $0.04
6/30/20225,900 shares $295.00 No ChangeN/A0 $0.05
5/31/20222,700 shares $123.39 No ChangeN/A0 $0.05
4/15/202216,900 shares $611.44 No ChangeN/A0 $0.04
2/28/2022212,900 shares $8.52 thousand +3,030.9%N/A0.2 $0.04
2/15/20226,800 shares $289.00 -89.5%N/A0 $0.04
1/31/202264,500 shares $2.55 thousand No ChangeN/A0.1 $0.04
12/31/2021100 shares $3.31 No ChangeN/A0 $0.03
12/15/2021100 shares $3.70 -99.6%N/A0 $0.04
11/30/202124,600 shares $883.14 +24,500.0%N/A0 $0.04
11/15/2021100 shares $3.82 -98.9%N/A0 $0.04

ELTP Short Interest - Frequently Asked Questions

Short interest is the volume of Elite Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 30th, investors have sold 2,991,818 shares of ELTP short. 0.32% of Elite Pharmaceuticals' shares are currently sold short. Learn More on Elite Pharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELTP shares currently have a short interest ratio of 2.8. Learn More on Elite Pharmaceuticals's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.32% of Elite Pharmaceuticals' floating shares are currently sold short.

Elite Pharmaceuticals saw a decline in short interest since the prior report. As of October 30th, there was short interest totaling 2,991,818 shares, a decline of 1.4% from the previous total of 3,034,556 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.32% of Elite Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceuticals" compare to Elite Pharmaceuticals: Inventiva S.A. Sponsored ADR (6.36%), Alto Neuroscience, Inc. (16.32%), Theravance Biopharma, Inc. (3.52%), Ardelyx, Inc. (12.27%), Collegium Pharmaceutical, Inc. (16.26%), Achieve Life Sciences, Inc. (17.94%), Cybin Inc. (3.93%), Zevra Therapeutics, Inc. (11.44%), Ovid Therapeutics (9.98%), Gyre Therapeutics, Inc. (2.22%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.66 billion), Invesco QQQ ($57.17 billion), iShares Russell 2000 ETF ($21.91 billion), SPDR S&P Biotech ETF ($10.53 billion), Union Pacific Corporation ($9.26 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.05 billion), Nebius Group N.V. ($7.85 billion), iShares 20+ Year Treasury Bond ETF ($7.81 billion), Moderna, Inc. ($7.36 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.20 billion). View all of the most shorted stocks.

Short selling ELTP is an investing strategy that aims to generate trading profit from Elite Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Elite Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELTP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELTP, twice per month. The most recent reporting period available is October, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ELTP:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

Short interest data for OTCMKTS:ELTP is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 11/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners
Why I'm selling my Snapback Indicator for just $7
For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...
Base Camp Trading | Sponsoredtc pixel
Every Starlink dish pays this stock
There's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...
Behind the Markets | Sponsoredtc pixel
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...
Weiss Ratings | Sponsoredtc pixel
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Watch This Now
Jensen Huang, the man who launched the AI boom, just called what Elon Musk is chasing "the final frontier of A...
StocksToTrade | Sponsoredtc pixel
Many investors are about to lose everything
Twenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...
Porter & Company | Sponsoredtc pixel
URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...
Paradigm Press | Sponsoredtc pixel
This 10.3% war bond closed once. It's finally open again.
Todd Phillips has spent 30 years studying safe-money income. His test for real retirement income: can it promi...
Eagle Publishing | Sponsoredtc pixel